Johnson & Johnson, the world’s biggest maker of health care products, has reportedly raised its takeover offer for Actelion, Europe’s largest biotech firm, as negotiations progress. People familiar with the talks said that Johnson & Johnson significantly increased its offer from an earlier bid of about $26 billion, which would be $242 per share, which...